Institute Information

The Shanghai Institute of Clinical Bioinformatics (SICB) is an independent, non-profit, professional organization committed to discovering and developing new approaches for clinical application of bioinformatics-associated sciences and technologies to understand molecular mechanisms and potential therapies for human diseases. The SICB missions are to integrate clinical phenomes with molecular omics for the discovery, research, and development of disease-specific biomarkers, mechanism-oriented understanding, and targeted-based medicine. SICB is especially strong in computational biology, spatiotemporal analyses, measurements of DNA and RNA sequencing, single-cell biomedicine, and artificial intelligent cells. SICB has unique research and postgraduate training programs and national expert resources in clinical bioinformatics. SICB has first-class scientific platforms to measure gene sequencing, genomics, proteomics, metabolomics, lipidomics, single-cell sequencing, target-based omics, spatiotemporal transcriptomics, and spatiotemporal molecular images.  SICB’s highest priority is to develop new concepts and theories to further define molecular mechanisms that underlie clinical and biological phenomena, develop computational analyses to support the process of innovations and validations, and discover new cell clusters and functions of genes and proteins in disease diagnosis, therapy, and prognosis.

Clinical and Translational Discovery (CTD), an open access journal, is an official publication of SICB.


For further information, please visit ctmworld.org or email [email protected].